Skip to main content Skip to navigation Skip to mobile navigation Skip to accessibility tools

Switchboard0151 556 5000

24/7 hotline (treatment side-effects)
The Clatterbridge Cancer Centre NHS Foundation Trust
Private care
Charity
  • Home
  • Patients and visitors
    • Patients and visitors
    • Treatment and care
      • Treatment and care
      • Treatments
      • Cancer types
      • Consultants
      • Your first visit
      • Hospital appointments
      • Video appointments
      • Inpatients
      • Health advice - eating well, exercise and cancer care
        • Health advice - eating well, exercise and cancer care
        • Physical activity and cancer care
        • Eating well and cancer care
      • Clinical trials
      • Visitors
      • Getting here
      • Isle of Man patients
      • Private and international patients
      • Advice and support
        • Advice and support
        • Arts programme
        • Benefits advice
        • Bereavement support and advice
        • Cancer information and support centres
        • Chaplaincy
        • Interpreters and help with additional needs
        • LGBTQ+ Patients
      • Feedback, compliments and complaints
      • Request your records (subject access requests)
        • Request your records (subject access requests)
        • Request your records - easy-read information
        • Subject Access Request Form
      • Referral and second opinion
      • Patient information leaflets
        • Patient information leaflets
        • Lung cancer nursing team
        • Radiotherapy
        • Contact x-ray brachytherapy for rectal cancer (Papillon)
        • You and your gastrostomy feeding tube
        • Insertion of a rectal spacer for radiotherapy
        • High Dose Rate (HDR) brachytherapy to the vaginal vault
        • Proton beam therapy to the eye
        • High Dose Rate (HDR) brachytherapy to the skin
        • High Dose Rate (HDR) brachytherapy for cancer of the cervix
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy in combination with external beam radiotherapy (EBRT)
        • Immunotherapy
        • Nasogastric tube - Being discharged with a nasogastric tube
        • You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath
        • You and your PICC line
        • Eating well and coping well with side-effects on a vegan diet
        • Low residue diet information
        • Adding extra nourishment to your food when you have diabetes
        • Eating well and coping with side-effects
        • Proton beam therapy: Frequently asked questions and other useful information
        • Hepato-pancreato-biliary (HPB) nursing and support team
        • Arthralgia
        • Immune-related hepatitis
        • Skin care advice for patients on immunotherapy treatment
        • Infliximab - frequently asked questions
        • Cancer of Unknown Primary
        • Your nasogastric (NG) feeding tube and medication
        • Lymphoedema advice
        • What to do after an extravasation
        • Scalp cooling - a guide for patients
        • Breast cancer nursing team
        • Prostate cancer nursing and support team
        • Skin cancer nursing team
        • Upper gastrointestinal (UGI) nursing and support team
        • Teenage and Young Adult service
        • Choosing a wig
        • Your cancer treatment in your community
        • Liver surveillance service
        • Supported self management and patient-directed open access - MGUS
        • Sick day rules for people on basal bolus or pre-mixed insulin
        • Patient information for referral for consideration of SABR
        • Simple lymphatic drainage - head and neck
        • Advice to patients with a cardiac implantable electronic device – pacemakers or ICDS
        • How can we help? (Holistic Needs Assessment)
        • Pituitary and craniopharyngioma – radiotherapy
        • My Medical Record - information for patients
        • Lenalidomide (Revlimid) switch to generic equivalents
        • Lidocaine 2% mouthwash
        • Driving and diabetes
        • Hypos (hypoglycaemia)
        • Sick day rules for people on once-daily long-acting insulin
        • Safe sharps disposal
        • Information for people with Type 2 diabetes commencing steroids
        • What are ketones?
        • Instructions for preparation prior to planning (prostate)
        • Chemotherapy group pre-assessment sessions
      • Communicating with patients
    • Our hospitals
    • Our services
    • Consultants
    • Get involved
  • Research and innovation
    • Research and innovation
    • Research
      • Research
      • Welcome to research
      • Our research
        • Our research
        • Performance reports in initiating and delivering research
      • Research sponsorship
      • Clinical trials
      • Find a clinical trial or research study
      • Meet the team
      • Research partnerships
      • Jargon buster
      • Biobank
      • Research Strategy
      • How you can get involved
      • Research passports, honorary research contracts and letters of access
      • Research news
      • Research achievements and publications
    • Innovation
      • Innovation
      • Welcome to innovation
  • Work with us
    • Work with us
    • Vacancies
    • Joining our team
    • Your career: Our recruitment pack
    • Staff benefits: why choose us
      • Staff benefits: why choose us
      • Staff networks
      • Staff Excellence Awards 2024
        • Staff Excellence Awards 2024
        • Staff Excellence Awards 2024 Event Brochure
    • Roles and careers we offer
      • Roles and careers we offer
      • Radiography
        • Radiography
        • Diagnostic radiography careers with us
        • Therapeutic radiography careers with us
      • Healthcare science
      • Physiotherapy
    • Staff profiles
    • Staff bank
    • Living locally
    • Apprenticeships
    • Work experience
    • Volunteering
    • Get involved
    • Staff privacy notice
  • Professionals
    • Professionals
    • Education and training
      • Education and training
      • Clinical education courses
      • Clinical scientist training
      • Communication skills
      • FRCR Part 2b mock exam
      • Nursing career pathway
        • Nursing career pathway
        • Nursing career pathway and competency framework toolkit
      • Papillon
      • Medical education and training
    • Clinical guidance
      • Clinical guidance
      • Acute oncology (AO) and CUP guidance
      • Immunotherapy guidance
      • Metastatic spinal cord compression (MSCC) guidance
      • Catheter and line care guidance
      • SACT protocols and guidance
        • SACT protocols and guidance
        • All protocols and guidance
        • Breast
        • CNS
        • Gastrointestinal
        • Germ cell
        • Gynaecological
        • Haematology
        • Head and neck
        • Lung
        • Miscellaneous
        • Renal
        • Sarcoma
        • Skin
        • Supportive therapies
        • Urology
      • Referring patients
        • Referring patients
        • CT referral guidance
        • Interventional radiology referral guidance
        • MRI referral guidance
        • Nuclear medicine referral guidance
        • PET-CT referral guidance
        • Ultrasound referral guidance
        • X-ray referral guidance
      • Haemato-Oncology (haematology) clinical guidance
    • Work with us
  • About us
    • About us
    • Who we are
    • Vision and strategy
      • Vision and strategy
      • Vision, mission and values
      • Strategies and plans
        • Strategies and plans
        • Five Year Strategic Plan
        • Green Plan
        • Innovation Strategy
        • People Commitment
        • Patient Experience Commitment
        • Quality Improvement and Learning Strategy
        • Research Strategy
    • How we're run
      • How we're run
      • Trust Board
        • Trust Board
        • Trust Board meetings and papers
      • Procurement
      • Council of Governors
        • Council of Governors
        • Our governors
      • Membership of our Trust
    • Who we work with
    • How we're doing
      • How we're doing
      • Our reports and accounts
      • Care Quality Commission
      • Equality, diversity and inclusion
      • Achievements and accreditations
      • Safe staffing
    • Our services
    • Our history
    • Publications and documents
    • Freedom of Information (FOI)
    • News
    • Get involved
    • C3 Magazine
  • Contact us
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn

Breast Cancer SACT Protocols

You are here:

  1. Home
  2. Professionals
  3. Clinical guidance
  4. SACT protocols and guidance
  5. Breast
Thumbnail Title
PDF file icon Enhertu (Trastuzumab Deruxtecan) HER2 Positive Advanced Breast Cancer Protocol
PDF file icon Epirubicin Weekly Advanced Breast Cancer
PDF file icon Eribulin Advanced Breast Cancer
PDF file icon Everolimus and Exemestane Advanced Breast Cancer
PDF file icon Kadcyla (Trastuzumab Emtansine) HER-2 Positive Breast Cancer
PDF file icon Neratinib Adjuvant Treatment Breast Cancer Protocol V1.1
PDF file icon Olaparib BRCA mutated HER2 negative early
PDF file icon Paclitaxel & Gemcitabine Advanced Breast Cancer Protocol
PDF file icon Paclitaxel & Trastuzumab
PDF file icon Paclitaxel Albumin (Abraxane) Breast Cancer V1.1
PDF file icon Paclitaxel Albumin (Abraxane) Breast Cancer V1.1
PDF file icon Paclitaxel Weekly Advanced Breast Cancer
PDF file icon Paclitaxel Weekly Neoadjuvant Breast Cancer
PDF file icon Paclitaxel with DD EC Adjuvant or Neoadjuvant Protocol V1.3 accepted changes
PDF file icon Paclitaxel with EC Adjuvant or Neoadjuvant Protocol V1.1
PDF file icon Paclitaxel-Carboplatin with dose dense EC Neoadjuvant Regimen Protocol V1.1
PDF file icon Palbociclib & Fulvestrant Locally advanced or metastatic breast cancer
PDF file icon Palbociclib Locally advanced or metastatic breast cancer
PDF file icon Pembrolizumab with Carboplatin Paclitaxel and EC Neoadjuvant Breast Cancer Regimen followed by Adjuvant Pembrolizumab
PDF file icon Pembrolizumab with Paclitaxel or Nab-paclitaxel as 1st line treatment for locally advanced metastatic triple negative breast cancer
  • ← Previous page
  • Page 1
  • Page 2
  • Page 3
  • Next page→

More in this section...

All protocols and guidance

CNS

Gastrointestinal

Germ cell

Gynaecological

Haematology

Head and neck

Lung

Miscellaneous

Renal

Sarcoma

Skin

Supportive therapies

Urology

Last updated 20th March 2024

  • Aintree
    Telephone: 0151 556 5958
  • Liverpool
    Telephone: 0151 556 5000
  • Wirral
    Telephone: 0151 556 5000
  • Other clinics
    Telephone: 0151 556 5000
  • Paddington
    Telephone: 0151 556 5000
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn
  • Compliments and complaints
  • Vacancies
  • Accessibility statement
  • Privacy
  • Freedom of information
  • CQC rating

Accessibility tools

Text size:
Contrast:

Created by Frank Ltd.

Return to header
Last accessibility toolbar action: none available